AURX
Price
$2.50
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Capitalization
117M
AVCTF
Price
$1.05
Change
+$0.11 (+11.70%)
Updated
Oct 6 closing price
Capitalization
388.54M
Interact to see
Advertisement

AURX vs AVCTF

Header iconAURX vs AVCTF Comparison
Open Charts AURX vs AVCTFBanner chart's image
Nuo Therapeutics
Price$2.50
Change-$0.00 (-0.00%)
Volume$477
Capitalization117M
Avacta Group
Price$1.05
Change+$0.11 (+11.70%)
Volume$9.9K
Capitalization388.54M
AURX vs AVCTF Comparison Chart in %
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURX vs. AVCTF commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Hold and AVCTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (AURX: $2.50 vs. AVCTF: $1.05)
Brand notoriety: AURX and AVCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 4% vs. AVCTF: 188%
Market capitalization -- AURX: $117M vs. AVCTF: $388.54M
AURX [@Biotechnology] is valued at $117M. AVCTF’s [@Biotechnology] market capitalization is $388.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileAVCTF’s FA Score has 0 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • AVCTF’s FA Score: 0 green, 5 red.
According to our system of comparison, AURX is a better buy in the long-term than AVCTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 3 TA indicator(s) are bullish while AVCTF’s TA Score has 4 bullish TA indicator(s).

  • AURX’s TA Score: 3 bullish, 5 bearish.
  • AVCTF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, AVCTF is a better buy in the short-term than AURX.

Price Growth

AURX (@Biotechnology) experienced а +11.04% price change this week, while AVCTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCTF($389M) has a higher market cap than AURX($117M). AVCTF YTD gains are higher at: 85.841 vs. AURX (78.450).
AURXAVCTFAURX / AVCTF
Capitalization117M389M30%
EBITDA-2.48MN/A-
Gain YTD78.45085.84191%
P/E RatioN/AN/A-
Revenue1.95MN/A-
Total Cash316KN/A-
Total Debt132KN/A-
FUNDAMENTALS RATINGS
AURX: Fundamental Ratings
AURX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURXAVCTF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
35%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
33%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 14 days ago
50%
Declines
ODDS (%)
Bearish Trend 26 days ago
73%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGRTX83.500.53
+0.64%
JPMorgan US Value R2
EXTGX59.360.37
+0.63%
Eaton Vance Tx-Mgd Growth 1.2 A
MEFOX71.510.06
+0.08%
Meehan Focus
GEMOX14.78-0.03
-0.20%
Goldman Sachs Emerging Mkt Eq ex. ChnInv
AAERX19.39-0.06
-0.31%
American Beacon International Eq R6

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
-0.07%
ALZN - AURX
30%
Poorly correlated
-5.93%
VRAX - AURX
27%
Poorly correlated
-1.06%
NCNA - AURX
26%
Poorly correlated
-1.36%
FENC - AURX
23%
Poorly correlated
-4.63%
QNCX - AURX
22%
Poorly correlated
-3.63%
More

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and KZIA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
KZIA - AVCTF
26%
Poorly correlated
+0.14%
PHMMF - AVCTF
20%
Poorly correlated
N/A
BETRF - AVCTF
15%
Poorly correlated
N/A
AURX - AVCTF
11%
Poorly correlated
-0.07%
BPMUF - AVCTF
9%
Poorly correlated
N/A
More